Trial Profile
Retrospective study, Evaluating Effects of Efavirenz on Central Nervous System in HIV-1 Infected patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Dec 2015
Price :
$35
*
At a glance
- Drugs Efavirenz (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions
- 18 Dec 2015 New trial record